News | February 04, 2009

MITA Responds to JAMA-Published Study on CTA

February 4, 2009 - The Medical Imaging & Technology Alliance (MITA) responds that the study by Jörg Hausleiter, M.D., in the Feb. 4 issue of the Journal of the American Medical Association (JAMA) correctly focuses on what providers need to know to ensure that computed tomography angiography (CTA) is utilized appropriately.

Even with the collective efforts to reduce radiation exposure, it’s important to point out that CTA, when used appropriately, minimizes other risks that more invasive procedures present to patients. Moreover, peer-reviewed research proves that CTA is more cost effective than catheterization for some cardiac patients, MITA states.

MITA endorses widespread adoption of appropriateness criteria and is encouraged that leading private health systems, such as Massachusetts General Hospital and United Health Care, are currently using or piloting it to guide the proper utilization of medical imaging technology.

In addition, the alliance supports efforts to harness health information technology (IT) to reduce duplicative scans and unnecessary risk to radiation exposure and looks forward to working with all stakeholders to develop interoperable imaging exchange standards so that health IT can contribute to realizing the imaging community’s goal of reducing radiation exposure.

MITA also supports the recent recommendation of the American Heart Association that health-care providers should diligently review patient records, including those from other medical institutions, to ensure that imaging studies are not needlessly repeated.

For more information: www. medicalimaging.org


Related Content

News | CT Angiography (CTA)

July 29, 2026 — Caristo Diagnostics has announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Home July 30, 2026
Home
News | CT Angiography (CTA)

July 9, 2026 — Elucid recently announced first patient enrollment in AI-Predict, a retrospective, international ...

Home July 13, 2026
Home
Feature | CT Angiography (CTA) | Kyle Hardner

Advances in coronary CT angiography (CCTA) over the past two decades have helped cardiologists detect heart disease in ...

Home February 06, 2026
Home
News | CT Angiography (CTA)

Jan. 9, 2026 — Effective January 1, 2026, Elucid's Plaque-IQ coronary plaque analysis has received a new Category I ...

Home January 09, 2026
Home
News | CT Angiography (CTA)

Dec. 11, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD), recently announced two ...

Home December 11, 2025
Home
News | CT Angiography (CTA)

Dec. 8, 2025 — In November, The Lancet published an international expert consensus review, “Contemporary, non-invasive ...

Home December 11, 2025
Home
News | CT Angiography (CTA)

Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal ...

Home October 30, 2025
Home
News | CT Angiography (CTA)

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Home October 29, 2025
Home
News | CT Angiography (CTA)

Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA). The ...

Home October 23, 2025
Home
News | CT Angiography (CTA)

Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 09, 2025
Home
Subscribe Now